MENU
IOVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Iovance Biotherapeutics (IOVA) Ownership - Who owns Iovance Biotherapeutics?
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells using therapies personalized for each patient... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
825 Industrial Road
Phone
+1 650 260-7120
Employees
557
Web
https://www.iovance.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.07B
P/E Ratio
N/A
Total Cash
323.78M
Projected Growth
N/A
Total Debt
58.26M
Revenue
164.07M
Risk (Beta)
1.08
Dividend Yield
N/A
Total Cash/Share
0.99
Total Debt/Equity
N/A
Revenue/Share
0.57 USD as % of share price
Fundamentals
IOVA
Capitalization
1.07B
P/E Ratio
N/A
Risk (Beta)
1.08
Dividend Yield
N/A
Total Cash
324M
Total Cash/Share
0.99
Total Debt
58.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.57%
Revenue
164M
ROE
N/A
Book Value
710M
P/B Ratio
1.50
Cash Flow
N/A
Earnings
-1.28
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
13K
Current Ratio
3.74
Current Revenue Per Employee
87940.34
Dividends Per Share - Security
N/A
EBITDA
-351.67M
Float
N/A
Float - Current
N/A
Gross Income Margin
38.20
Revenue To Assets
-44.02
Shares Held By Institutions
4.87B
Shares Outstanding - Current
328M
Total Liabilities
200M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-55.000
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biotechnological products for the treatment of cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
825 Industrial Road
Phone
+1 650 260-7120
Employees
557
Web
https://www.iovance.com